These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27838376)

  • 1. Expression and purification of biologically active recombinant human paraoxonase 1 from a Drosophila S2 stable cell line.
    Yun H; Yu J; Kim S; Lee N; Lee J; Lee S; Kim ND; Yu C; Rho J
    Protein Expr Purif; 2017 Mar; 131():34-41. PubMed ID: 27838376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Farag HA; Agrawal P; Doctor BP; Nambiar MP
    Toxicol In Vitro; 2011 Jun; 25(4):905-13. PubMed ID: 21382471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
    Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
    Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.
    Lee N; Yun H; Lee C; Lee Y; Kim E; Kim S; Jeon H; Yu C; Rho J
    J Microbiol Biotechnol; 2021 Jan; 31(1):144-153. PubMed ID: 33144547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1.
    Valiyaveettil M; Alamneh Y; Biggemann L; Soojhawon I; Doctor BP; Nambiar MP
    Biochem Biophys Res Commun; 2010 Dec; 403(1):97-102. PubMed ID: 21040699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides.
    Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
    Rochu D; Chabrière E; Masson P
    Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
    Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
    Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in amino acid residues in the binding pockets dictate substrate specificities of mouse senescence marker protein-30, human paraoxonase1, and squid diisopropylfluorophosphatase.
    Belinskaya T; Pattabiraman N; diTargiani R; Choi M; Saxena A
    Biochim Biophys Acta; 2012 May; 1824(5):701-10. PubMed ID: 22401958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of organophosphorus compound hydrolysis by native and recombinant human prolidase.
    Chandrasekaran L; Belinskaya T; Saxena A
    Toxicol In Vitro; 2013 Feb; 27(1):499-506. PubMed ID: 22677456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
    Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
    FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.
    Tripathy RK; Aggarwal G; Bajaj P; Kathuria D; Bharatam PV; Pande AH
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1642-1662. PubMed ID: 28161867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
    Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
    Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 1 status as a risk factor for disease or exposure.
    Richter RJ; Jarvik GP; Furlong CE
    Adv Exp Med Biol; 2010; 660():29-35. PubMed ID: 20221868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1 (PON1) status and substrate hydrolysis.
    Richter RJ; Jarvik GP; Furlong CE
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):1-9. PubMed ID: 19071155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.
    Stevens RC; Suzuki SM; Cole TB; Park SS; Richter RJ; Furlong CE
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12780-4. PubMed ID: 18711144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
    Bajaj P; Tripathy RK; Aggarwal G; Pande AH
    Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new post-intoxication treatment of paraoxon and parathion poisonings using an evolved PON1 variant and recombinant GOT1.
    Goldsmith M; Ashani Y; Margalit R; Nyska A; Mirelman D; Tawfik DS
    Chem Biol Interact; 2016 Nov; 259(Pt B):242-251. PubMed ID: 27256520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.